VEVIX | VMVAX | VEVIX / VMVAX | |
Total Expense Ratio | 0.58 | 0.07 | 829% |
Annual Report Gross Expense Ratio | 0.58 | 0.07 | 829% |
Fund Existence | 15 years | 14 years | - |
Gain YTD | 3.030 | 5.532 | 55% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000000 | 3000 | 66,667% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17.7B | 30.6B | 58% |
Annual Yield % from dividends | 1.16 | 2.26 | 51% |
Returns for 1 year | -3.97 | 9.76 | -41% |
Returns for 3 years | 7.62 | 28.18 | 27% |
Returns for 5 years | 43.67 | 71.82 | 61% |
Returns for 10 years | 52.72 | 93.07 | 57% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PDT | 13.34 | 0.14 | +1.06% |
John Hancock Premium Dividend Fund | |||
TMFM | 26.80 | 0.12 | +0.44% |
Motley Fool Mid-Cap Growth ETF | |||
TLH | 99.99 | 0.43 | +0.43% |
iShares 10-20 Year Treasury Bond ETF | |||
BDIV | 21.46 | 0.09 | +0.41% |
AAM Brentview Dividend Growth ETF | |||
BLDG | 25.21 | -0.09 | -0.35% |
Cambria Global Real Estate ETF |